FRESENIUS MEDICAL CARE AG Dividends Paid To Noncontrolling Interests Classified As Financing Activities
FRESENIUS MEDICAL CARE AG (FMS) reported Dividends Paid To Noncontrolling Interests Classified As Financing Activities of EUR 61.81 million for the 3-month period ending 2020-03-31, per its 6-K filed 2020-05-06.
Discontinued › Cash Flow › Financing Activities
ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities · last filed 2020-05-06
- FRESENIUS MEDICAL CARE AG dividends paid to noncontrolling interests classified as financing activities for the quarter ending 2020-03-31 was 61.81M EUR, a 12.63% increase year-over-year.
- FRESENIUS MEDICAL CARE AG dividends paid to noncontrolling interests classified as financing activities for the quarter ending 2019-12-31 was 92.30M EUR, a 9.52% decline year-over-year.
- FRESENIUS MEDICAL CARE AG dividends paid to noncontrolling interests classified as financing activities for the quarter ending 2019-09-30 was 327.10M EUR, a 4.57% increase year-over-year.
- FRESENIUS MEDICAL CARE AG dividends paid to noncontrolling interests classified as financing activities for the quarter ending 2019-06-30 was -178.11M EUR.
| Period end | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 3 month | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 3 month as first filed | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 6 month | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 6 month as first filed | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 9 month | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 12 month | Dividends Paid To Noncontrolling Interests Classified As Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-03-31 | 61.81M EUR 6-K · filed 2020-05-06 | 154.10M EUR derived: sum of 2 quarters · filed 2020-05-06 | 481.21M EUR derived: sum of 3 quarters · filed 2020-05-06 | 303.10M EUR derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2019-12-31 | 92.30M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 419.40M EUR derived: sum of 2 quarters · filed 2020-02-20 | 241.29M EUR derived: sum of 3 quarters · filed 2020-02-20 | 296.17M EUR 20-F · filed 2020-02-20 | |||
| 2019-09-30 | 327.10M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 149.00M EUR derived: sum of 2 quarters · filed 2019-10-31 | 203.87M EUR 6-K · filed 2019-10-31 | 305.88M EUR derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2019-06-30 | -178.11M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -123.23M EUR 6-K · filed 2019-07-30 | -21.23M EUR derived: sum of 3 quarters · filed 2020-05-06 | 291.57M EUR derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2019-03-31 | 54.87M EUR 6-K · filed 2020-05-06 | -54.87M EUR 6-K · filed 2019-05-02 | 156.88M EUR derived: sum of 2 quarters · filed 2020-05-06 | 469.68M EUR derived: sum of 3 quarters · filed 2020-05-06 | 402.12M EUR derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | 102.01M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 414.81M EUR derived: sum of 2 quarters · filed 2020-02-20 | 347.24M EUR derived: sum of 3 quarters · filed 2020-02-20 | 296.29M EUR 20-F · filed 2020-02-20 | -296.29M EUR 20-F · filed 2019-02-20 | ||
| 2018-09-30 | 312.80M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 245.23M EUR derived: sum of 2 quarters · filed 2019-10-31 | 194.28M EUR 6-K · filed 2019-10-31 | 259.95M EUR derived: sum of 4 quarters · filed 2020-02-20 | |||
| 2018-06-30 | -67.56M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -118.51M EUR 6-K · filed 2019-07-30 | 118.51M EUR 6-K · filed 2018-08-01 | -52.85M EUR derived: sum of 3 quarters · filed 2020-02-20 | 24.28M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2018-03-31 | -50.95M EUR 6-K · filed 2019-05-02 | 50.95M EUR 6-K · filed 2018-05-03 | 14.71M EUR derived: sum of 2 quarters · filed 2020-02-20 | 91.84M EUR derived: sum of 3 quarters · filed 2020-02-20 | 255.27M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2017-12-31 | 65.66M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 142.79M EUR derived: sum of 2 quarters · filed 2020-02-20 | 306.22M EUR derived: sum of 3 quarters · filed 2020-02-20 | 386.34M EUR 20-F · filed 2020-02-20 | |||
| 2017-09-30 | 77.13M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-10-30 | 240.56M EUR derived: sum of 2 quarters · filed 2018-10-30 | 320.68M EUR 6-K · filed 2018-10-30 | ||||
| 2017-06-30 | 163.43M EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-01 | 243.55M EUR 6-K · filed 2018-08-01 | |||||
| 2017-03-31 | 80.12M EUR 6-K · filed 2018-05-03 | ||||||
| 2016-12-31 | -294.30M EUR 20-F · filed 2019-02-20 | 294.30M EUR 20-F · filed 2018-02-27 | |||||
| 2015-12-31 | 256.40M EUR 20-F · filed 2018-02-27 |